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Objective To generate a global reference for caesarean section
(CS) rates at health facilities.
Design Cross-sectional study.
Setting Health facilities from 43 countries.
Population/Sample Thirty eight thousand three hundred and
twenty-four women giving birth from 22 countries for model
building and 10 045 875 women giving birth from 43 countries
for model testing.
Methods We hypothesised that mathematical models could
determine the relationship between clinical-obstetric characteristics
and CS. These models generated probabilities of CS that could be
compared with the observed CS rates. We devised a three-step
approach to generate the global benchmark of CS rates at health
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General obstetrics
facilities: creation of a multi-country reference population,
building mathematical models, and testing these models.
Main outcome measures Area under the ROC curves, diagnostic
odds ratio, expected CS rate, observed CS rate.
Results According to the different versions of the model, areas
under the ROC curves suggested a good discriminatory capacity
of C-Model, with summary estimates ranging from 0.832 to 0.844.
The C-Model was able to generate expected CS rates adjusted for
the case-mix of the obstetric population. We have also prepared
an e-calculator to facilitate use of C-Model (www.who.int/
reproductivehealth/publications/maternal_perinatal_health/c-model/en/).
Conclusions This article describes the development of a global
reference for CS rates. Based on maternal characteristics, this tool
was able to generate an individualised expected CS rate for health
facilities or groups of health facilities. With C-Model, obstetric
teams, health system managers, health facilities, health insurance
companies, and governments can produce a customised reference
CS rate for assessing use (and overuse) of CS.
Tweetable abstract The C-Model provides a customized benchmark
for caesarean section rates in health facilities and systems.
Keywords Benchmarking, caesarean delivery rates, caesarean
section rates, logistic regression.
Linked article This article is commented on by M Robson, p.437
in this issue. To view this article mini commentary visit http://
dx.doi.org/10.1111/1471-0528.13619.
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Introduction
Caesarean section (CS) is the most commonly performed
surgical operation in the world. This surgery is lifesaving
when performed in time to overcome certain types of dys-
tocia and other complications. However, as for any major
surgery, it presents increased risk of adverse outcomes,
including blood transfusion, anaesthesia complications,
internal organ injury, infection, thromboembolic disease,
neonatal respiratory distress, and other complications of
iatrogenic prematurity1,2 When carried out without medical
indication, there is little benefit added and the harm that
can be caused becomes more evident.
Since its introduction in obstetric practice, caesarean section
rates have continuously increased in both developed and devel-
oping countries.1,3–5 In 1985, participants of a World Health
Organization (WHO) meeting held in Fortaleza, Brazil, stated
that CS rates higher than 15% could hardly be justified from a
medical standpoint.6 Over the years, this figure became the ref-
erence for what is considered the ‘ideal’ CS rate. Nevertheless,
most countries have observed a steep increase of CS rates in
the last three decades.3,7–13 A substantial proportion of this
increment was due to unnecessary operations attributable to
non-evidence-based indications, professional convenience,
maternal request, and over-medicalisation of childbirth14. This
is an important issue for health systems in many parts of the
world, not only because of the additional short- and long-term
health risks it causes but also regarding increased costs associ-
ated with caesarean births.
Recent data from developed countries suggests that CS
rates of around 15% at the population level are possible, safe
and compatible with optimum health outcomes for mothers
and babies.15 However, at the level of an individual health
facility, it is often difficult to determine an appropriate rate of
CS. Differences in the case-mix and the obstetric profile com-
plicate the applicability and relevance of a universal reference
rate for CS. Based on data disaggregation in ten obstetric
groups, Robson proposed in 2001 a classification system that
enables understanding of the internal structure of the CS rate
at individual health facilities and identification of strategic
population groups to prevent unnecessary use of CS.16–18 In
2015, the WHO issued an official statement concerning CS
rates and promoting the use of the Robson classification as an
tool for optimising the CS rate at health facilities.19
Building on the clinical-obstetric characteristics that
form the base of the Robson classification, we carried out
this study with the objective of developing and testing a
global reference for CS rates at health facilities.
Methods
We hypothesised that mathematical models could deter-
mine the relationship between clinical-obstetric characteris-
tics and CS. These models would be able to generate
probabilities of CS that could be compared with observed
CS rates. This approach is widely accepted for benchmark-
ing performance of intensive care units. In intensive care,
mathematical models are used to estimate the probability
of mortality and this information is compared with the
actual mortality.20 Thus, we devised a three-step approach
to generate the global benchmark of CS rates at health facil-
ities: (1) creation of a multi-country reference population;
(2) building mathematical models; (3) testing mathematical
models with available multicentre facility-based data in var-
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ious countries, contexts and health systems. The overall
analysis flow is presented in Figure 1.
Building a reference population
A critical step for the development of a mathematical model
able to generate a reference CS rate is the population that
will serve as the basis for establishing the relationship
between maternal characteristics and the probability of cae-
sarean section. Due to the global nature of our endeavour,
we assumed we would need a multi-country population,
with relatively low CS rates and, at the same time, good out-
comes of labour and childbirth. We used the WHO Multi-
Country Survey on Maternal and Newborn Health (WHO
MCS) to create our reference population. Detailed descrip-
tion of this study has been published elsewhere.21 Briefly,
the WHO MCS was a cross-sectional study implemented in
359 health facilities in 29 countries. Countries, provinces (or
other equivalent political divisions within countries), and
health facilities were randomly selected to participate in the
WHO MCS through a stratified, multistage cluster sampling
strategy. Health facilities were only eligible if they dealt with
at least 1000 deliveries per year and had the capacity to pro-
WHO Multicountry Survey on Maternal and Newborn Health
359 health facilities
314,623 women
(29 countries)
1,841 Abortions, laparotomies for 
ectopic pregnancy, other/unknown mode 
of delivery
359 health facilities
312,782 women with vaginal delivery or 
caesarean section
293 health facilities with high caesarean 
section rates (above percentile 50) OR 
high intra-partum related perinatal 
mortality (above percentile 50)
270,145 women
Reference population: Group A
66 health facilities with low caesarean section rates (below percentile 50) AND low 
intra-partum related perinatal mortality (below percentile 50)
42,637 women
(22 countries)
Group A1
(90% of a random split for model building)
38,324 women
(66 health facilities from 22 countries)
Group A2
(10% of a random split for model testing)
4,313 women
(66 health facilities from 22 countries)
Call for external validation studies
(including WHO MCS network, International Network of Obstetric 
Survey Systems (INOSS) and other experts)
C-Model validation
24 databases
10,045,875 women (3,035,465 caesarean sections)
(43 countries)
Figure 1. Analysis flowchart for model building and validation.
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vide CS. Between May 2010 and December 2011 the WHO
MCS included 314 623 women from Africa, Asia, the East-
ern Mediterranean region, and Latin America.
For the creation of the reference population we consid-
ered that the intrapartum related perinatal mortality (i.e.
intrapartum stillbirth plus neonatal deaths that took place
in the first postpartum day) was a reasonable indicator of
quality of care.22 We assumed that health facilities with low
CS rates and low intrapartum perinatal mortality had few
unnecessary CS and good maternal and perinatal outcomes.
Therefore, we selected this population to serve as reference
and base for mathematical modelling. To implement this
reasoning, we first calculated the facility-specific CS rate
and intrapartum-related perinatal mortality rate in each of
the 359 health facilities that participated in the WHO
MCS. Next, we identified the health facilities that would
have both low CS rates and low intrapartum perinatal mor-
tality. Low CS rates and low intrapartum perinatal mortal-
ity were both relative to the facilities that participate in the
WHO MCS and defined as below the respective percentile
50. We selected this specific cut-off (i.e. percentile 50)
because the median is commonly used as a reference for
defining what is low or high in sufficiently large samples.
Thus, hospitals that presented both CS rates and
intrapartum-related perinatal mortality below the 50th per-
centile constituted the reference population (in Supporting
Information Appendix S1, Figure S2, Group ‘A’). We used
simple frequencies and proportions to describe essential
characteristics of the reference population.
Building the C-Model
The WHO MCS collected data on various socio-demo-
graphic and clinical-obstetric characteristics, severity mark-
ers, and complications that were analysed as candidate
predictors for CS. First, we assessed the reference popula-
tion and the WHO MCS country data using the Robson
classification. Secondly, we carried out univariate analyses
of the reference population to explore the relationship of
several candidate predictors and the occurrence of CS.
Third, a logistic regression random effects model was used
to determine the relationship between candidate predictors
and CS. As part of the regression analysis, the reference
population was divided in two subpopulations: ‘A1’ (used
for model building), and ‘A2’ (used for testing the internal
validity of the prediction model).23 To maximise represen-
tativeness and at the same time ensure the ability to test
the internal validity of the model, 90% of the reference
population was randomly allocated to population ‘A1’ and
the remainder (10%) to population ‘A2’.
We named our mathematical model ‘C-Model’ and built
four versions to be used according to the availability of
data at the local level. The first version has a limited num-
ber of variables and is essentially based on the variables
used in the Robson classification (i.e. parity, previous CS,
multiple pregnancy, provider-initiated childbirth, presenta-
tion, and preterm birth). The second version added a
demographic variable (i.e. maternal age), the third one the
presence of organ dysfunction or ICU admission, and the
fourth variables of diagnosis of selected complications (i.e.
placenta praevia, abruptio placenta, chronic hypertension,
pre-eclampsia, renal disease and HIV). Only variables that
contributed significantly to each model version were
retained. The different versions of C-Model estimate the
probability of CS based on the presence or absence of
significant predictors.23
Testing the C-Model
The internal validity of C-Model was assessed in subpopu-
lations A1 and A2. The discriminatory power was assessed
through ROC curves. Classification tables, accuracy tests,
and model performance tests were also carried out.
An international call for validation studies of the C-Model
was issued in February 2014. Members of the WHO MCS
research network, the International Network of Obstetric
Surveys Systems (INOSS), and independent researchers
received an invitation to test the C-Model in their databases.
To ensure standardisation, an external validation protocol
with detailed instructions including variable recoding, com-
puting probabilities of CS using the C-Model coefficients,
generating ROC curves, and other information were pro-
vided. The researchers that responded to the call returned
their results via e-mail and the information was compiled in
a master spreadsheet (Supporting Information Appendix
S2). For each database, estimates generated by C-Model ver-
sions with incomplete data (i.e. when a variable was not
available in the dataset) were discarded. Random effects
meta-analyses were used to generate summary estimates of
areas under the ROC curves. Based on the results of these
meta-analyses, the C-Model version with largest number of
variables was considered able to generate the ‘best estimate’
of CS probability. The deviation of the observed CS rate (and
an uncertainty range) was determined for each database con-
sidering the best estimate of CS probability. This uncertainty
range was arbitrarily defined by the authors as 20% because
differences >20–25% are commonly considered clinically sig-
nificant or appreciable differences.24 The ratio between
observed and predicted CS (the standardised caesarean
section ratio) was determined.
All analysis considered cluster effect at the health facility
level and at the country level. STATA Version 13.0
(www.stata.com/stata13/), PASW Statistics 18, Release Ver-
sion 18.0.0 (SPSS, Inc., 2009, Chicago, IL, USA,
www.spss.com), R package version 3.1.1 (http://www.r-pro-
ject.org/) and MEDCALC Version 11.6.1.0 (MedCalc Soft-
ware, 2011, Mariakerke, Belgium, www.medcalc.org) were
used in the C-Model analysis.
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The HRP specialist panel (WHO scientific staff and
external, independent researchers) on epidemiological
research reviewed and approved the WHO MCS study pro-
tocol for technical content. The WHO MCS study was
approved by the WHO ethical review committee and the
relevant ethical clearance mechanisms in all countries. The
relevant ethical and administrative clearances for analysis of
databases that provided data for C-Model building and
testing were obtained.
Results
A total of 359 health facilities in 29 countries participated in
the WHO MCS, which included 314 623 women between 1
May 2010, and 31 December 2011. Among these health
facilities, the 50th percentile for CS rate was 30% and the
50th percentile for the intrapartum-related perinatal deaths
was 6.8 deaths per 1000 livebirths. Health facilities below
these values (i.e. facilities with <30% of caesarean births and
<6.8 intrapartum-related perinatal deaths deaths per 1000
births) were selected to provide the reference population
(Group A). The reference population included 42 637
women from 66 health facilities in 22 countries. Table 1
presents the demographic characteristics of health indicators
and countries of the reference population. Table 2 presents
the results of the Robson classification in the reference pop-
ulation. Supporting Information Table S1 presents the
results of univariate analysis of the relationship of CS and
selected characteristics in the Group A; these characteristics
were later included in different versions of the C-Model.
Random split of the reference population rendered two
subgroups: sub-group A1 with 38 324 women and sub-
group A2 with 4313 women. The mixed-effects logistic
regression modelling was carried out in subgroup A1 and
Table 1. Characteristics and outcomes of the reference population
(Group A), including health facilities and countries*
All women (n = 42 637)
Age
Data available 42 551
Mean (SD) 27.0 years (5.9)
Marital status
Data available 41 022
Without a partner 4973 (12.1%)
With a partner 36 049 (87.9%)
Schooling
Data available 36 770
Mean (SD) 9.7 years (4.4)
Outcomes
Livebirths 42 361
Caesarean sections 7629 (17.9%)
Perinatal deaths 276 (6.5/1000 livebirths)
Intrapartum-related
perinatal deaths
127 (3.0/1000 livebirths)
Maternal deaths 10 (23.6/100 000 livebirths)
Maternal near-miss cases 111 (2.6/1000 livebirths
Severe maternal outcomes 121 (2.9/1000 livebirths)
Case-fatality ratio 11:1
Health facilities
Data available 62 health facilities
Location (%)
Urban 31 (50.0)
Peri-urban 15 (24.2)
Rural 16 (25.8)
Level of care (%)
Primary 13 (21.0)
Secondary 33 (53.2)
Tertiary 15 (24.2)
Other 1 (1.6)
Teaching hospital (%)
Yes 38 (61.3)
No 24 (38.7)
Maternity beds (%)
<50 46 (74.2)
50–100 10 (16.3)
>100 6 (9.7)
Countries (%)
Data available 42 637
Afghanistan 2102 (4.9)
Angola 1808 (4.2)
Argentina 2507 (5.9)
Brazil 1555 (3.6)
Cambodia 1980 (4.6)
China 1053 (2.5)
Ecuador 216 (0.5)
India 2007 (4.7)
Japan 3096 (7.3)
Mongolia 5101 (12.0)
Nepal 490 (1.1)
Nicaragua 41 (0.1)
Nigeria 924 (2.2)
Table 1. (Continued)
All women (n = 42 637)
Palestine 980 (2.3)
Pakistan 497 (1.2)
Peru 637 (1.5)
Philippines 4391 (10.3)
Qatar 3950 (9.3)
Sri Lanka 3973 (9.3)
Thailand 842 (2.0)
Uganda 1791 (4.2)
Vietnam 2696 (6.3)
*Considering the 359 health facilities that participated in the WHO
MCS, the reference group is composed of those with caesarean
section rates and perinatal mortality below the 50th percentile): 66
health facilities with low caesarean section rates and low perinatal
mortality from 22 countries.
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produced four versions of the C-Model, all of them com-
puting the clustering effect. Table 3 presents the variables
included in each model together with their coefficients and
other relevant details. These versions were tested in sub-
group A2. Overall, in subgroup A1, areas under ROC
curves ranged from 0.867 to 0.879, and in subgroup A2
from 0.873 to 0.886. The diagnostic odds ratio of the C-
Model (determined based on cut-off points derived from
ROC curves) ranged from 17.49 to 18.54 in subgroup A1
and from 18.12 to 19.11 in subgroup A2. The percentage
of cases correctly classified ranged from 82.2 to 83.6% in
subgroup A2, according to the different version of the
model. Visual assessment of calibration plots (based on
quintiles of C-Model caesarean-section probabilities) in
both subgroups indicates satisfactory performance, with
predicted CS rates following observed CS rates. Appendix
S1 contains supplementary information related to the
model building and testing, including ROC curves, diag-
nostic accuracy, classification tables, calibration plots and
other tests whose results suggested satisfactory model
performance (for details refer to Supporting Information
Figures S3–S5 and Tables S5–S8).
The C-Model was tested in 24 independent databases
(Supporting Information Tables S3–S9) including data of
over 10 million women and 3 million CS performed in 43
countries. Figure S1 and Table S4 represent all countries
where the C-Model was tested. According to the different
versions of the model, areas under the ROC curves sug-
gested a good discriminatory capacity of C-Model, with
summary estimates ranging from 0.832 to 0.844 (Table S2).
Appendix S1 presents areas under the ROC curves for indi-
vidual databases and meta-analysis details. Table S3 pre-
sents the CS rate, the best estimate of predicted CS rate
(with a reference range of CS rate), the absolute deviation
of the best estimate, and the standardised CS ratio by data-
base that tested the C-Model. The C-Model was able to
generate expected CS rates that are adjusted for the case-
mix of the obstetric population. In databases with low CS
rates and good perinatal outcomes (e.g. Finland) the devia-
tion from observed and estimated CS rates is minimal (i.e.
<1.0%). Hospitals with high CS rates presented larger devi-
ations from what would be expected for the clinical and
obstetric characteristics of the population. Detailed results
of the studies that conducted external validation analysis
Table 2. Description of the reference population (Group A) according to Robson’s classification
Group Description CS/group C-
Section
rate, %
Relative
size, %
CS/all
births,
%
1 Nulliparous women with a single cephalic pregnancy,
at greater than or equal to 37 weeks in spontaneous labour
1182/
12 069
9.8 29.3 2.9
2 Nulliparous women with a single cephalic pregnancy, at greater than
or equal to 37 weeks’ gestation who either had labour induced or were
delivered by caesarean section before labour (provider-initiated childbirth)
1446/3620 39.9 8.8 3.5
3 Multiparous women, without a previous uterine scar, with a single cephalic
pregnancy at greater than or equal 37 weeks in spontaneous labour
503/
16 538
3.0 40.1 1.2
4 Multiparous women, without a previous uterine scar, with a single cephalic
pregnancy at greater than or equal to 37 weeks’ gestation who either
had
labour induced or were delivered by caesarean
section before labour (provider-initiated childbirth)
624/2631 23.7 6.4 1.5
5 All multiparous women, with at least one previous uterine scar and a
single cephalic pregnancy at greater than or equal to 37 weeks’ gestation
2194/2948 74.4 7.2 5.3
6 All nulliparous women with a single breech pregnancy 391/498 78.5 1.2 0.9
7 All multiparous women with a single breech pregnancy
including women with previous uterine scars
471/638 73.8 1.5 1.1
8 All women with multiple pregnancies, including
women with previous uterine scars
222/385 57.7 0.9 0.5
9 All women with a single pregnancy with a transverse or oblique
lie, including women with previous uterine scars
140/158 88.6 0.4 0.3
10 All women with a single cephalic pregnancy at less than or equal to 36
weeks’ gestation, including women with previous scars
432/1718 25.1 4.2 1.0
Overall 7605/41 203 18.5 100.0 18.5
Number of missing values = 1434.
432 ª 2015 World Health Organization; licensed by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists.
Souza et al.
are presented in the Appendix S1 (Figures S6–S9) and
Appendix S2.
Discussion
Main findings
This article describes the development of a global reference
for benchmarking CS rates at health facilities. Based on
maternal characteristics, the C-Model is able to generate an
individualised reference rate for CS for health facilities and
groups of health facilities, as well as the probability of a
woman of having a CS in a particular facility. This tool
was developed based on a multicountry population and
tested with data from over 10 million women from 43
countries. With the C-Model, obstetric teams, health facili-
ties, health system managers, health insurance organisa-
tions, and governments will be able to obtain a customised
reference rate for CS; this reference rate is adapted to
the clinical, demographical, and obstetric profile of the
maternal population. This tool provides an objective
estimate to assess, compare, and drive C-section rates,
locally and nationally. To facilitate use, an electronic calcu-
lator was developed and made available through the link
www.who.int/reproductivehealth/publications/maternal_peri-
natal_health/c-model/en/. This online calculator not only
provides estimates of CS probabilities for individual women,
but also generates estimates for facility databases that can
be uploaded in various formats into the free online system
(see Appendix S1).
Strengths and limitations
This is the largest study aiming at establishing the mathemat-
ical relationship of maternal characteristics and CS, with a
large sample size, multicountry data and extensive external
testing. Another positive feature of our approach is that,
depending on local data availability, more sophisticated ver-
sions of the model can be used. It should be noted that the
gain in accuracy between the different versions of the model
is small, possibly because the most basic version of the model
already includes the main predictors of C-section.
Table 3. C-Model coefficients (four versions depending on the availability of data)
v1.0 v1.1 v1.2 v1.3
Constant (b) –3.392134 –3.992549 –3.989357 –4.015252
Covariates
Obstetric characteristics
(x1) Parity (b1) –0.559968 –0.760441 –0.76173 –0.77531
(x2) Previous C-section (b2) 2.842534 2.873179 2.87813 2.922222
(x3) Multiple pregnancy (b3) 1.694844 1.722743 1.721366 1.834027
(x4) Provider-initiated childbirth* (b4) 2.747953 2.708164 2.686502 2.634921
(x5) Presentation (b5) 2.922391 2.911992 2.9241 2.985162
(x6) Preterm birth (b6) 0.368073 0.364223 0.285275 –
Demographics and severity
(x7) Maternal age (b7) – 0.734265 0.728236 0.71104
(x8) Organ dysfunction OR ICU admission (b8) – – 1.499462 0.661417
Complications
(x9) Placenta praevia (b9) – – – 3.796513
(x10) Abruptio placentae (b10) – – – 2.741255
(x11) Chronic hypertension (b11) – – – 0.561991
(x12) Pre-eclampsia (b12) – – – 0.98718
(x13) Renal disease (b13) – – – 1.301346
(x14) HIV (b14) – – – 1.310211
Determining the probability of caesarean section**
Rules:
• In general, if condition is absent, make xi = 0; if condition is present, make xi = 1; • For presentation, if cephalic, make x5 = 0; if breech,
make x5 = 1; if transverse lie or other presentation, make x5 = 2; • For pre-eclampsia, if absent, make x12 = 0; in case of pre-eclampsia, make
x12 = 1; in case of eclampsia, make x12 = 2
Calculate Logit, using the relevant coefficients for each model, as follows:
Logit = b + (x1 b1) + (x2 b2) + . . . + (xi bi)
Calculate the probability of caesarean section
ProbCS = eLogit/(1 + eLogit)
*Includes both induction of labour and caesarean section before labour.
**An electronic calculator is through the link www.who.int/reproductivehealth/publications/maternal_perinatal_health/c-model/en/
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Some weaknesses of this analysis should be noted. First, we
generated the reference population using a low risk sub-sam-
ple of the WHO MCS database. Despite efforts to ensure the
best possible quality in this database (considering the scope
and magnitude of the original study) minor data heterogene-
ity could be expected and has been discussed in previous
publications21. For the same reason, we were not able to
include in our models all possible predictors of CS. Some
important information, such as maternal weight and height,
were not available in the WHO MCS database and thus were
not considered. At this point it is uncertain whether the
included predictors have compensated (at least partially) for
the absence of other important predictors and how these
other predictors compare with the included ones.
Secondly, as we were intending to use individual mater-
nal characteristics to estimate C-section probabilities, we
did not include in our modelling the characteristics of
health facilities, which could represent a limitation for gen-
erating estimates in health facilities with severe shortages of
essential supplies, human resources or other factors that
are necessary to perform safe CS. Similarly, the C-Model
estimates do not account for CS performed for convenience
(e.g. maternal request, health professional or health service
preference), so that mostly medically necessary CS are
modelled and counted. In any case, when the C-Model esti-
mates show appreciable differences from actual CS rates,
this could trigger further inquiries and actions to improve
quality of care, decision-making, practices, and results.
Thirdly, most of the validation data comes from routine
databases, which may add some issues concerning com-
pleteness and accuracy of the information on clinical risk
factors in those databases. In addition, these routine data
could be associated to some heterogeneity as some health
facilities or countries may not respond uniformly to mater-
nal characteristics and CS predictors; we tried to account
for this heterogeneity by suggesting the use of ranges of
uncertainty for each estimate.
Finally, ‘Induction of labour’ and ‘C-section before
labour’ were treated as ‘provider-initiated childbirth’. This
was performed in line with the Robson classification that
lumps together in the same category induction of labour
and CS before labour. We assumed that as a reference to
all childbirths, the C-Model should be able to generate esti-
mates to all obstetric population, including those women
with CS before labour. As we could not generate a coeffi-
cient specific to CS before labour (it would have a 100%
association with CS), we decided to consider induction of
labour as a reasonable proxy for CS before labour during
model development. This decision partly accounts for the
provider intent of ending the pregnancy while also consid-
ering that many women with an indication to end the
pregnancy might actually undergo induction of labour first
instead of undergoing CS before labour.
Interpretation
This analysis builds on previous efforts to establish the rela-
tionship of maternal characteristics and CS. These efforts
have explored, among others, comparisons of caesarean rates
across different populations and institutions, application of
dynamic econometric models to assess aggregate level deter-
minants of caesarean section rates in developed countries,
adjustments for Robson’s Ten-Group Classification System
(TGCS), and clinical and socio-demographic variables of the
mother and the fetus for inter-hospital comparisons of CS
rates.10,13,25,26 However, whereas previous approaches tended
to be limited in terms of the number of countries and global
representativeness, the present work used a multicountry ref-
erence population and extended testing to maximise global
applicability. Based on our findings, we believe we have
developed a robust and potentially useful tool to improve the
ability of health facilities and systems to objectively estimate
the overuse and under-use of caesarean sections and use this
information to motivate change.
Conclusion
Potential applications of the C-Model include its use as
part of clinical audits and negotiated targets within health
services. Countries could set their reference CS rate based
on the obstetric profile of their population and not
depend on a single ideal CS rate. However, caution
should be exercised: C-Model estimates should not be
used to guide decision making in individual clinical prac-
tice and should not replace clinical judgment (e.g. an
individual woman may need a CS despite a C-Model esti-
mate suggesting very low probability of CS). Researchers
around the world are encouraged to further test the C-
Model and report their findings, particularly as part of
strategies designed to optimise the use of CS in health
services. It would be desirable to develop alternative mod-
els and, if possible, test other potential predictors such as
maternal height, maternal weight, and BMI. Studies on
equitable use of CS could also use the C-Model to esti-
mate over-use and under-use of CS in specific popula-
tions, such as low-income or low-education populations.
Although there is a global trend towards increased rates
of CS, under-use of this intervention remains an issue in
many countries, particularly among underprivileged popula-
tions. The C-Model is a tool designed to guide obstetric
teams, health managers, and other stakeholders in the com-
plex task of optimising the use of CS. Through a customised
estimate of CS rates, the C-Model may provide a locally rel-
evant reference of what would be an optimal CS rate.
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